ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
The data from a number of clinical trials investigating a once-yearly infusion of5 mg zoledronic acidshow a marked efficacy of this intervention in the treatment of primary and secondary osteoporosis with a combination of fracture risk reduction and prevention of bone loss at key skeletal sites. Rec...
| Published in: | Остеопороз и остеопатии |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2016-12-01
|
| Subjects: | |
| Online Access: | https://endojournals.ru/index.php/osteo/article/view/9203 |